Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells
In Vivo · 2024
DOI: 10.21873/invivo.13799 ↗Kurz gefasst
Fallbericht in der Zeitschrift In Vivo, 2024. Verfasst von Jing-Yuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Hydrogen, Subarachnoid Hemorrhage, Arthritis, Rheumatoid. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Most nontraumatic subarachnoid hemorrhages (SAHs) are caused by ruptured saccular aneurysms, often resulting in a devastating clinical event characterized by high mortality and significant morbidity among survivors. Numerous studies have confirmed the neuroprotective effects of the molecular hydrogen due to its unique biological properties. CASE REPORT: We present the case of a 44-year-old female with aneurysmal SAH with rheumatoid arthritis (RA) and newly diagnosed systemic lupus erythematosus (SLE), complicated by acute ischemic infarction. Despite surgical, pharmacological and non-pharmacological interventions, including embolization of the aneurysm, immunosuppressant, non-vitamin K antagonist oral anticoagulant (NOAC), and plasmapheresis, loss of consciousness continued. The patient began daily treatment with hydrogen capsules, resulting in increased in Treg cells, Breg cells, increased TIM3+ expression on Tc cells, and the conversion of anti-dsDNA from positive to negative. Her clinical symptoms stabilized without adverse effects. CONCLUSION: This case highlights the potential benefits of molecular hydrogen therapy in managing aneurysmal SAH with underlying autoimmune disease, warranting further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
- Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
- The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
- School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.
Zitieren
APA
Chen, J. Y., Lu, J. W., Feng, S. W., Ho, Y. J., Lui, S. W., Hsieh, T. Y., & Liu, F. C. (2024). Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells. In Vivo. https://doi.org/10.21873/invivo.13799
Vancouver
Chen JY, Lu JW, Feng SW, Ho YJ, Lui SW, Hsieh TY, et al. Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells. In Vivo. 2024. doi:10.21873/invivo.13799
BibTeX
@article{Chen2024,
author = {Chen, Jing-Yuan and Lu, Jeng-Wei and Feng, Shao-Wei and Ho, Yi-Jung and Lui, Shan-Wen and Hsieh, Ting-Yu and Liu, Feng-Cheng},
title = {Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13799}
}
EUVIMED